Minerva Neurosciences (NERV) Misses Q1 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($1.13), $0.12 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• AutoZone beats profit view but misses on revenue
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'